GLP-1 RAs for type 2 diabetes significantly lower one-year mortality, especially in those also diagnosed with obstructive sleep apnea.
The FDA will complete the approval process for certain medications in 1 to 2 months, a change from the usual 10-month review.
Low-carbohydrate diets, especially ones focused on animal-based protein and fat, were overall associated with an increased risk for type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback